Page last updated: 2024-09-03

2'-cyano-2'-deoxyarabinofuranosylcytosine and docetaxel anhydrous

2'-cyano-2'-deoxyarabinofuranosylcytosine has been researched along with docetaxel anhydrous in 1 studies

Compound Research Comparison

Studies
(2'-cyano-2'-deoxyarabinofuranosylcytosine)
Trials
(2'-cyano-2'-deoxyarabinofuranosylcytosine)
Recent Studies (post-2010)
(2'-cyano-2'-deoxyarabinofuranosylcytosine)
Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010) (docetaxel anhydrous)
310612,1103,2166,920

Protein Interaction Comparison

ProteinTaxonomy2'-cyano-2'-deoxyarabinofuranosylcytosine (IC50)docetaxel anhydrous (IC50)
Kinesin-like protein KIF11Homo sapiens (human)0.0014
Nucleotide-binding oligomerization domain-containing protein 2Homo sapiens (human)5.0119

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benhadji, K; Calvo, F; Chiao, J; Cvitkovic, E; Faivre, S; Galmarini, CM; Ghoul, A; Green, SR; Le Tourneau, C; Raymond, E; Serova, M1

Other Studies

1 other study(ies) available for 2'-cyano-2'-deoxyarabinofuranosylcytosine and docetaxel anhydrous

ArticleYear
Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells.
    British journal of cancer, 2007, Sep-03, Volume: 97, Issue:5

    Topics: 5'-Nucleotidase; Antineoplastic Agents; Apoptosis; Arabinonucleosides; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Cytarabine; Cytosine; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Drug Synergism; Equilibrative Nucleoside Transporter 1; Gemcitabine; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Taxoids

2007